Genasense
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Genasense, covering 2008-02-11 to 2017-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 2]